.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Cantor Fitzgerald
Mallinckrodt
Novartis
Boehringer Ingelheim
Johnson and Johnson
Medtronic
Fish and Richardson
Chinese Patent Office
UBS

Generated: November 21, 2017

DrugPatentWatch Database Preview

Clinigen Hlthcare Company Profile

« Back to Dashboard

What is the competitive landscape for CLINIGEN HLTHCARE, and what generic alternatives to CLINIGEN HLTHCARE drugs are available?

CLINIGEN HLTHCARE has three approved drugs.

There are two US patents protecting CLINIGEN HLTHCARE drugs.

There are thirty-three patent family members on CLINIGEN HLTHCARE drugs in sixteen countries.

Summary for Clinigen Hlthcare

International Patents:33
US Patents:2
Tradenames:3
Ingredients:3
NDAs:3
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Clinigen Hlthcare
ETHYOL
amifostine
INJECTABLE;INJECTION020221-002Sep 10, 1999DISCNNoNo► Subscribe► Subscribe ► Subscribe
Clinigen Hlthcare
TOTECT
dexrazoxane hydrochloride
INJECTABLE;INJECTION022025-001Sep 6, 2007RXYesYes► Subscribe► Subscribe ► Subscribe
Clinigen Hlthcare
FOSCAVIR
foscarnet sodium
INJECTABLE;INJECTION020068-001Sep 27, 1991RXYesYes► Subscribe► Subscribe► Subscribe
Clinigen Hlthcare
ETHYOL
amifostine
INJECTABLE;INJECTION020221-001Dec 8, 1995APRXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Clinigen Hlthcare

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Clinigen Hlthcare
ETHYOL
amifostine
INJECTABLE;INJECTION020221-002Sep 10, 1999► Subscribe► Subscribe
Clinigen Hlthcare
ETHYOL
amifostine
INJECTABLE;INJECTION020221-001Dec 8, 1995► Subscribe► Subscribe
Clinigen Hlthcare
ETHYOL
amifostine
INJECTABLE;INJECTION020221-001Dec 8, 1995► Subscribe► Subscribe
Clinigen Hlthcare
FOSCAVIR
foscarnet sodium
INJECTABLE;INJECTION020068-001Sep 27, 1991► Subscribe► Subscribe
Clinigen Hlthcare
FOSCAVIR
foscarnet sodium
INJECTABLE;INJECTION020068-001Sep 27, 1991► Subscribe► Subscribe
Clinigen Hlthcare
FOSCAVIR
foscarnet sodium
INJECTABLE;INJECTION020068-001Sep 27, 1991► Subscribe► Subscribe
Clinigen Hlthcare
FOSCAVIR
foscarnet sodium
INJECTABLE;INJECTION020068-001Sep 27, 1991► Subscribe► Subscribe
Clinigen Hlthcare
ETHYOL
amifostine
INJECTABLE;INJECTION020221-002Sep 10, 1999► Subscribe► Subscribe
Clinigen Hlthcare
ETHYOL
amifostine
INJECTABLE;INJECTION020221-002Sep 10, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for CLINIGEN HLTHCARE drugs

Drugname Dosage Strength Tradename Submissiondate
amifostine
For Injection500 mg/vial
ETHYOL
4/16/2004

Non-Orange Book Patents for Clinigen Hlthcare

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,586,476 Methods for the treatment of nephro-disorders using aminothiol compounds► Subscribe
7,105,575Methods for the treatment of neuro- disorders using aminothiol compounds► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Clinigen Hlthcare Drugs

Country Document Number Estimated Expiration
Australia1718499► Subscribe
Austria265215► Subscribe
European Patent Office1459752► Subscribe
Canada2367240► Subscribe
European Patent Office1039887► Subscribe
Portugal1039887► Subscribe
Hong Kong1043054► Subscribe
European Patent Office1537861► Subscribe
Russian Federation2252761► Subscribe
Spain2220424► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Teva
Mallinckrodt
Medtronic
Federal Trade Commission
Argus Health
Baxter
UBS
Queensland Health
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot